When you’re depressed, take a green depression glass and put it on your head to help with depression
People with depression are more likely to develop cancer, according to a new study.
People who take green depression glasses to treat their depression are twice as likely to die from their cancer as people who don’t, researchers found.
A green depression eye patch is designed to reduce symptoms of depression and help with its symptoms, such as headaches and mood swings.
Researchers in Germany examined data from the German National Health Insurance (Bundesmedizin für Geschichte des Forschungsgesundts) and National Institute for Health Research’s German Depression Cohort Study, which includes more than 40,000 people.
The study was published in the journal JAMA Internal Medicine.
They found that people who had a green eye patch were twice as unlikely to die as people with a white depression eye.
The researchers found that about 20 percent of people with depression have at least one symptom associated with their condition.
Those with more severe depression had higher rates of developing cancer.
In addition, people with depressive symptoms were more likely than their counterparts without depression to have had an MRI scan, the study found.
“Our study shows that depression is a common, but complex, condition and that it is associated with a number of risk factors for developing cancer,” said Dr. Michael B. Cohen, a professor of epidemiology and biostatistics at the Johns Hopkins University School of Medicine.
“For people with mild to moderate depression, the risk of developing a cancer diagnosis was about 2.7 times higher than for those with moderate or severe depression.”
The study also found that having depression may be linked to a person’s likelihood of having a more aggressive form of cancer.
People with depressive and anxiety disorders were also more likely in the study to have a genetic mutation that makes them more likely of developing metastatic disease.
Dr. Michael G. Steinberg, a co-author of the study, is an assistant professor of preventive medicine at the Icahn School of Hospital Medicine at Mount Sinai in New York City.
He is also the director of the Icah Center for Clinical Epidemiology, a Johns Hopkins Cancer Center on Aging Research Institute.
He said that this is the first study to link depression to cancer.
“In the general population, depression is associated not only with depression but also with other psychological disorders, including anxiety and eating disorders,” he said.
“This is particularly true in younger people, who are at higher risk of having depression, and we can also find an increased risk of cancer in people with more aggressive forms of depression.”
Dr. Steinberger said that it will be important to follow the link between depression and cancer in future studies.
“It’s an important topic for research, and in the coming years, we’re going to be able to use the information from this study to develop treatments that target the underlying causes of depression,” he explained.